November 22nd 2024
The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.
November 21st 2024
Novel Single-Cell Whole Genome Amplification Technology Made Commercially Available at ASHG 2020
November 4th 2020With the presentation of research supporting the use of PTA technology, BioSkryb also launched its ResolveDNA platform for commercial use at ASHG 2020, held virtually on Oct. 27–30, 2020.
Sai Life Sciences’ Screening Capabilities Enhanced with Expanded Cellular Analysis Platforms
October 7th 2020Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.